Literature DB >> 25083483

The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma.

Anthony R Glover1, Justin S Gundara1, Olov Norlén2, James C Lee1, Stan B Sidhu3.   

Abstract

Prophylactic central neck dissection (pCND) for management of papillary thyroid carcinoma (PTC) is controversial. Compared to many malignancies, PTC has a high overall survival but local recurrence due to lymph node metastases continue to present management challenges. Unlike lateral cervical nodal metastasis metastasis, central neck nodal metastasis are unable to be reliably detected clinically or radiologically at pre-operative assessment. Residual disease (recurrent or persistent) typically requires re-operative surgery in the central compartment, which carries a heightened risk of significant morbidity. These nodal groups can be accessed during the index thyroidectomy for PTC. Thus, pCND offers potential to reduce the rates of recurrence and the need for re-operative surgery in the central neck. This benefit needs to be balanced with the potential morbidity risk from pCND itself at the index resection. This review will discuss the advantages and disadvantages of pCND with regard to long-term outcomes and potential morbidity. The rationale of pCND will be discussed, along with the indications for ipsilateral and contralateral pCND, the role of re-operative surgery for recurrence and the use of selective versus routine pCND. Strategies to select higher risk patients for pCND with the use of molecular markers will be addressed, along with a discussion of quality of life (QoL) research in PTC.

Entities:  

Keywords:  Lymph node; elective; metastasis; morbidity; prophylactic

Year:  2013        PMID: 25083483      PMCID: PMC4115751          DOI: 10.3978/j.issn.2227-684X.2013.10.05

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  69 in total

1.  Pattern and predictive factors of regional lymph node metastasis in papillary thyroid carcinoma: a prospective study.

Authors:  Inn Chul Nam; Jun Ook Park; Young Hoon Joo; Kwang Jae Cho; Min Sik Kim
Journal:  Head Neck       Date:  2012-01-20       Impact factor: 3.147

Review 2.  Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  F Pacini; M G Castagna; L Brilli; G Pentheroudakis
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

3.  History of the recurrent laryngeal nerve: from Galen to Lahey.

Authors:  Edwin L Kaplan; George I Salti; Manuela Roncella; Noreen Fulton; Mark Kadowaki
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

Review 4.  Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone.

Authors:  Edward J Chisholm; Elena Kulinskaya; Neil S Tolley
Journal:  Laryngoscope       Date:  2009-06       Impact factor: 3.325

5.  Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis.

Authors:  Tarek Zetoune; Xavier Keutgen; Daniel Buitrago; Hasan Aldailami; Huibo Shao; Madhu Mazumdar; Thomas J Fahey; Rasa Zarnegar
Journal:  Ann Surg Oncol       Date:  2010-07-02       Impact factor: 5.344

6.  A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.

Authors:  Aleksandra Popadich; Olga Levin; James C Lee; Stephanie Smooke-Praw; Kevin Ro; Maisam Fazel; Asit Arora; Neil S Tolley; Fausto Palazzo; Diana L Learoyd; Stan Sidhu; Leigh Delbridge; Mark Sywak; Michael W Yeh
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

7.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.

Authors:  Mark Sywak; Lachlan Cornford; Paul Roach; Peter Stalberg; Stan Sidhu; Leigh Delbridge
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

8.  Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?

Authors:  Raul Alvarado; Mark S Sywak; Leigh Delbridge; Stan B Sidhu
Journal:  Surgery       Date:  2009-03-27       Impact factor: 3.982

9.  Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer.

Authors:  Kathryn G Schuff; Stephen M Weber; Babak Givi; Mary H Samuels; Peter E Andersen; James I Cohen
Journal:  Laryngoscope       Date:  2008-05       Impact factor: 3.325

10.  BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.

Authors:  Gina M Howell; Marina N Nikiforova; Sally E Carty; Michaele J Armstrong; Steven P Hodak; Michael T Stang; Kelly L McCoy; Yuri E Nikiforov; Linwah Yip
Journal:  Ann Surg Oncol       Date:  2012-09-01       Impact factor: 5.344

View more
  9 in total

Review 1.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

2.  Effect of prophylactic central neck dissection on the surgical outcomes in papillary thyroid cancer: experience in a single center.

Authors:  Dilek Yazıcı; Bülent Çolakoğlu; Burçin Sağlam; Havva Sezer; Yersu Kapran; Özlem Aydın; Mehmet Onur Demirkol; Faruk Alagöl; Tarık Terzioğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-12       Impact factor: 2.503

3.  Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model.

Authors:  Xiang Zhong; Yunpeng Lu; Xu Yin; Quhui Wang; Feiran Wang; Zhixian He
Journal:  Gland Surg       Date:  2022-02

4.  Long-Term Survival in Patients With Papillary Thyroid Cancer Who Did Not Undergo Prophylactic Central Lymph Node Dissection: A SEER-Based Study.

Authors:  Jun Long Song; Ling Rui Li; Zhi Liang Xu; Juan Juan Li; Sheng Rong Sun; Chuang Chen
Journal:  World J Oncol       Date:  2022-06-02

5.  Risk Factors for Predicting Lymph Nodes Posterior to Right Recurrent Laryngeal Nerve (LN-prRLN) Metastasis in Thyroid Papillary Carcinoma: A Meta-Analysis.

Authors:  Cunfu Li; Jun Xiang; Yunjun Wang
Journal:  Int J Endocrinol       Date:  2019-03-31       Impact factor: 3.257

6.  Response to Treatment is Highly Predictable in cN0 Patients with Papillary Thyroid Carcinoma.

Authors:  Alexander Gorshtein; Carlos Benbassat; Eyal Robenshtok; Ilan Shimon; Dania Hirsch
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

7.  Predictive Value of BRAFV600E Mutation for Lymph Node Metastasis in Papillary Thyroid Cancer: A Meta-analysis.

Authors:  Jing-Yong Song; Shi-Ran Sun; Fang Dong; Tao Huang; Bin Wu; Jing Zhou
Journal:  Curr Med Sci       Date:  2018-10-20

8.  Carbon nanoparticles guide contralateral central neck dissection in patients with papillary thyroid cancer.

Authors:  Wenbin Yu; Guohui Xu; Junyong Sun; Naisong Zhong
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

9.  Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.

Authors:  A N DiMarco; M S Wong; J Jayasekara; D Cole-Clark; A Aniss; A R Glover; L W Delbridge; M S Sywak; S B Sidhu
Journal:  BJS Open       Date:  2019-02-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.